Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 1 39 0 3 14 40
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 1 44 2 5 14 144
Estimating Lifetime or Episode-of-illness Costs 0 0 1 100 0 3 15 259
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 51 2 2 8 147
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 1 1 1 11 1 1 13 80
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 35 1 1 14 123
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 287 1 3 7 851
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 1 41 0 1 5 145
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 5 17 72 72 11 36 61 62
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 1 15 1 1 5 33
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 2 51 0 2 12 47
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 2 3 13 26
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 1 7 3 9 17 37
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 1 57 0 1 7 221
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 2 67 3 4 24 69
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 1 4 39 0 1 6 86
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 41 1 1 7 154
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 53 0 1 10 204
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 1 1 3 471 3 3 23 1,293
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 0 144 0 2 14 475
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 35 1 1 6 44
Total Working Papers 7 20 91 1,710 32 84 295 4,540


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 0 0 0 4 15
Comparing alternative models: log vs Cox proportional hazard? 1 2 4 138 2 4 11 544
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 2 3 5 304
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 4 0 0 2 27
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 27 0 3 18 190
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 1 4 43
Estimating lifetime or episode‐of‐illness costs under censoring 0 1 2 14 0 2 6 65
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 3 134 0 0 8 390
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 1 136 0 2 9 333
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 1 2 3 20
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 3 12 81 0 8 40 205
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 4 69 1 2 15 172
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 4 0 0 2 12
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 1 31 0 1 4 121
Personalized Medicine in the Context of Comparative Effectiveness Research 0 1 4 13 2 5 29 98
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 1 1 6 47
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 1 1 1 1 5 15
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 1 2 49 2 4 6 202
The impact of comparative effectiveness research on health and health care spending 0 0 0 32 0 2 10 252
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 1 1 11 876 4 8 62 2,513
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 0 1 7 27
Total Journal Articles 2 9 45 1,633 16 50 256 5,595


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 1 23 4 8 30 175
Total Software Items 0 0 1 23 4 8 30 175


Statistics updated 2020-09-04